Preparation method and identification method of fungaltoxin AOD
Through two-stage light-proof culture and multi-step extraction combined with thin-layer chromatography, mycotoxin AOD was successfully prepared and identified, solving the problem of lack of preparation methods in China, and achieving efficient purification of mycotoxins and ensuring food safety.
Patent Information
- Application Number
- CN202411305750.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-08
AI Technical Summary
The lack of standard preparation methods for mycotoxin AOD in China has limited the development of relevant research, especially in terms of food hygiene and safety.
Fusarium oats was activated by two-stage light-proof culture. Through the extraction steps of methanol aqueous solution, ether aqueous solution and trichloromethane, combined with thin-layer chromatography and liquid chromatography-tandem mass spectrometry, mycotoxin AOD was isolated and purified, and the mycotoxin AOD was constructed. Simple identification method.
It has achieved efficient preparation and identification of mycotoxin AOD, filled the domestic preparation gap, provided a fast and effective method, enriched domestic analytical and detection methods, and ensured food safety.
Smart Images

Figure CN118910178A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biological detection, and in particular to a preparation method and an identification method of mycotoxin AOD. Background Art
[0002] Fusarium headblight, caused by Fusarium, is an important disease that harms many cereal crops such as wheat, barley, oats, corn, rice and rye. It is widely distributed in warm and humid regions such as North America, Europe and Asia. In recent years, it has gradually spread with global warming. Crops can be infected with Fusarium during growth or storage. After infection with Fusarium, not only does it cause a decrease in crop yield, but more importantly, the Fusarium toxins produced are directly retained and accumulated in the grains of cereals, seriously threatening the health of humans and animals.
[0003] Fusarium avenaceum is one of the pathogens of Fusarium fusarium. Fusarium avenaceum is a fungus that grows in cooler conditions in northern latitudes and is the most common Fusarium species found in Norwegian cereals. Like several other Fusarium species, it can cause plant diseases such as Fusarium head blight and foot rot. Isolates of Fusarium avenaceum have been shown to produce antibiotic Y, fusarin, butenolide, chlamysporin, fusarin, fusarin C, and fusarin. In addition, previous results of cytotoxicity studies on Fusarium avenaceum rice cultures and Fusarium avenaceum contaminated cereal extracts showed that this species is able to produce metabolites other than the known toxic metabolites. Recently, the cytotoxicity of a rice culture of Avena cocci was attributed to the high content of legumin and an unknown compound, which was identified as the mycotoxin AOD (2-amino-14,16-dimethyloctadecan-3-ol) (Uhlig S, Petersen D, Flaoyen A, Wilkins A. 2-Amino-14,16-dimethyloctadecan-3-ol, a new sphingosine analogue toxin in the fungal genus Fusarium. Toxicon 2005, 46(5): 513-522.) on the porcine epithelial kidney cell line PK (15) under bioanalytical guidance. Its chemical formula is C 20 H 43 NO, structural formula Figure 5 shown.
[0004] Given the presence of the fungal toxin AOD in cereals such as wheat and fruits, which poses a serious threat to the safety of humans and animals, in recent years, the analysis and detection of the fungal toxin AOD, in vivo and in vitro toxicity studies, and safety evaluation have attracted widespread attention, which is also of great significance for ensuring food hygiene and safety in my country (Solhaug A, Torgersen ML, Holme JA, Wiik-Nilsen J, Thiede B, Eriksen GS. The Fusarium mycotoxin, 2-Amino-14,16-dimethyloctadecan-3-ol (AOD) induces vacuolization in HepG2 cells. Toxicology 2020, 433.).
[0005] However, the preparation of mycotoxin AOD standards and reference materials is still a blank in China, and many European and American countries currently follow the embargo on the sale of toxins and their metabolite standards to non-Australian Convention countries, which has set up a large obstacle for domestic research on such toxins. Therefore, it is urgent to develop a simple and effective method for preparing mycotoxin AOD and identifying mycotoxin AOD. Summary of the invention
[0006] The purpose of the present invention is to provide a method for preparing and identifying mycotoxin AOD to solve the problems existing in the above-mentioned prior art. The present invention provides a method for effectively preparing mycotoxin AOD, and has the advantage of being simple.
[0007] To achieve the above object, the present invention provides the following solutions:
[0008] The present invention provides a method for preparing mycotoxin AOD, comprising the following steps:
[0009] (1) using a two-stage dark-proof culture to activate Fusarium solani to obtain a toxin-producing culture;
[0010] (2) extracting the toxin-producing culture with methanol-water solution, blowing the obtained extract to dryness with nitrogen, and dissolving it with ether-water solution to obtain an ether complex;
[0011] (3) extracting the ether complex with ethyl acetate, blowing the obtained extract to dryness with nitrogen, and dissolving it with chloroform to obtain a primary toxin extract;
[0012] (4) using 1-deoxysphingolipid as a reference, separating the mycotoxin AOD in the primary toxin extract by thin layer chromatography, and recovering it by scraping to obtain a crude extract of the mycotoxin AOD; the developing solvent used in the thin layer chromatography is an aqueous solution containing chloroform and methanol, and the volume ratio of chloroform, methanol and water in the developing solvent is 60:40:1;
[0013] (5) The crude extract of mycotoxin AOD is extracted with chloroform to obtain purified mycotoxin AOD.
[0014] Preferably, the development time of the thin layer chromatography is 30-90 min.
[0015] Preferably, the culture medium used in the two-stage light-proof culture is a sterile rice culture medium; the components of the sterile rice culture medium include rice and water, and the mass ratio of the rice to water is 1:3.
[0016] Preferably, the two-stage dark-proof culture comprises a first stage of dark-proof culture and a second stage of dark-proof culture;
[0017] The conditions of the first stage of dark culture are: 25°C, 180-250rpm, dark culture for 2 weeks;
[0018] The conditions for the second stage of dark-proof culture are: 10° C., 180-250 rpm, dark-proof culture for 2 weeks.
[0019] Preferably, the number of extractions in step (2) is 4 times; the volume percentage of methanol in the methanol aqueous solution is 50%; the amount of methanol aqueous solution used in each extraction is 150-300 mL; and the volume ratio of ether to water in the ether aqueous solution is 1:1.
[0020] Preferably, the number of extractions in step (3) is 3, and the amount of ethyl acetate used in each extraction is 20 mL.
[0021] Preferably, the extraction times in step (5) is 3 times; and the amount of chloroform used in each extraction is 10 mL.
[0022] The present invention provides a method for detecting mycotoxin AOD and its derivatives, comprising the following steps:
[0023] Liquid chromatography-tandem mass spectrometry was used to detect the fungal toxin AOD;
[0024] Among them, mobile phase A is an aqueous solution of methanol-formic acid containing ammonium formate, and the volume ratio of methanol, water and formic acid in the aqueous solution of methanol-formic acid containing ammonium formate is 58:41:1; mobile phase B is a methanol-formic acid solution containing ammonium formate; the volume ratio of methanol and formic acid in the methanol-formic acid solution containing ammonium formate is 99:1; the concentration of ammonium formate in the mobile phase A and the mobile phase B is 5mM.
[0025] Preferably, the chromatographic column used in the liquid chromatography-tandem mass spectrometry is ZORBAX Eclipse Plus C18, and the sample loading volume is 10 μL.
[0026] Preferably, the liquid chromatography-tandem mass spectrometry detection performs qualitative analysis on the fungal toxin AOD by MS2 scanning mode, and performs quantitative analysis on the fungal toxin AOD by MRM mode.
[0027] The present invention discloses the following technical effects:
[0028] The present invention provides a method for preparing the mycotoxin AOD, which fills the gap in the preparation of the mycotoxin AOD in China. Compared with the previous silica gel column chromatography method, the conventional column elution method for separation and purification is changed, and the mycotoxin AOD is quickly and efficiently separated from the crude toxin extract by TLC (thin layer chromatography). It can be seen that the present invention provides a simple method for efficiently preparing and purifying AOD toxins. The present invention also constructs a method for quantifying fungal virus AOD by LC-MS / MS (liquid chromatography-tandem mass spectrometry), enriching the domestic method for identifying mycotoxins. The present invention uses TLC separation to obtain the mycotoxin AOD, and qualitatively and quantitatively analyzes AOD and its derivatives by LC-MS / MS, thereby providing a practical and effective, simple method for quickly preparing, purifying and identifying the avenous Fusarium toxin AOD. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0030] Figure 1 This is a flow chart for the culture, preparation, extraction, purification and identification of the fungal toxin AOD;
[0031] Figure 2 The TLC method is used to separate and purify the fungal toxin AOD. The red circle in the figure is the 1-deoxysphingosine standard, and the red box is the color-developed part of the initial extraction of the fungal toxin AOD in the sample;
[0032] Figure 3 The MS2 spectrum of the crude toxin of Fusarium solani BNCC210949 was identified by liquid chromatography-mass spectrometry, in which the AOD ion peaks of the fungal toxin were 314.0 ([M+H] + ), 296.3([M+H-H2O] +), 279.3([M+H-H2O-NH3] + );
[0033] Figure 4 The MRM mode is used to determine the AOD content in the extract, where the black solid line is the total ion current of the sample, the red solid line is the fungal toxin AOD, the purple solid line is the fungal toxin AOD structural analog phytosphingosine (t18:0), the blue solid line and the green solid line are the possible acylation products of the two fungal toxin AODs, Relative Responses is the relative response, Retention Time is the retention time, and Mobile Phase B is the mobile phase B;
[0034] Figure 5 It is the structural formula of the fungal toxin AOD. DETAILED DESCRIPTION
[0035] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0036] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0037] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0038] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0039] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0040] Example 1
[0041] Strain: Fusarium solani BNCC210949 (Beina Biotech);
[0042] Implementation steps by process Figure 1 To be specific:
[0043] The Fusarium solani BNCC210949 was transferred from the cold storage slant to a potato culture medium plate for activation, and cultured at 25°C for 7 days to obtain the activated Fusarium solani BNCC210949;
[0044] In a 1L Erlenmeyer flask, add 100g of rice and then 300mL of distilled water to prepare sterile rice culture medium under high pressure;
[0045] A small amount of Fusarium solani BNCC210949 was inoculated from a potato culture medium plate into the above rice culture medium, first cultured at 25°C and 220 rpm for 2 weeks, and then transferred to 10°C and 220 rpm for 2 weeks to obtain a fermentation product, which was a pink paste.
[0046] The toxin-producing culture was repeatedly extracted four times with 300 mL of 50% by volume methanol solution and centrifuged. The methanol extracts were combined and nitrogen blown to dryness. The sample was then dissolved in 40 mL of ether aqueous solution system, in which the volume ratio of water to 50% by volume ether was 1:1. After dissolution, the obtained complex was repeatedly extracted three times with 20 mL of ethyl acetate. The ethyl acetate extracts were combined and nitrogen blown and redissolved in 3 mL of chloroform to obtain the initial toxin extract.
[0047] Using 1-deoxysphingolipid (m18:0) as an indicator, the toxin primary extract was separated by TLC method to separate the fungal toxin AOD. The results obtained after iodine staining of the TLC plate are shown in Figure 2 .Depend on Figure 2 It can be seen that the primary extract of mycotoxin AOD exists in the chloroform extract.
[0048] The crude extract of mycotoxin AOD was recovered by scraping, and the crude extract of mycotoxin AOD was repeatedly extracted three times with 10 mL of chloroform, combined with nitrogen blowing, and then re-dissolved with 1 mL of methanol. The obtained sample was identified by LC-MS / MS method in positive ion mode. The instrument model and mobile phase conditions are shown in Table 1.
[0049] Table 1 LC-MS / MS conditions used for analysis of toxin AOD
[0050]
[0051] MS 2Spectrum see Figure 3 The content of the product was monitored by MRM (m / z 314.3->296.3). The results are shown in Figure 4 .Depend on Figure 3 and Figure 4 It can be seen that the fungal toxin AOD can be obtained using the method of the present invention.
[0052] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. A method for preparing mycotoxin AOD, characterized in that: The following steps are involved: (1) using a two-stage dark-proof culture to activate Fusarium solani to obtain a toxin-producing culture; (2) extracting the toxin-producing culture with methanol-water solution, blowing the obtained extract to dryness with nitrogen, and dissolving it with ether-water solution to obtain an ether complex; (3) extracting the ether complex with ethyl acetate, blowing the obtained extract to dryness with nitrogen, and dissolving it with chloroform to obtain a primary toxin extract; (4) using 1-deoxysphingolipid as a reference, separating the mycotoxin AOD in the primary toxin extract by thin layer chromatography, and recovering it by scraping to obtain a crude extract of the mycotoxin AOD; the developing solvent used in the thin layer chromatography is an aqueous solution containing chloroform and methanol, and the volume ratio of chloroform, methanol and water in the developing solvent is 60:40:1; (5) The crude extract of mycotoxin AOD is extracted with chloroform to obtain purified mycotoxin AOD.
2. The preparation method according to claim 1, characterized in that: The development time of the thin layer chromatography is 30-90 min.
3. The preparation method according to claim 1, characterized in that: The culture medium used in the two-stage light-proof culture is a sterile rice culture medium; the components of the sterile rice culture medium include rice and water, and the mass ratio of the rice to water is 1:
3.
4. The preparation method according to claim 1, characterized in that: The two-stage light-proof culture includes a first stage of light-proof culture and a second stage of light-proof culture; The conditions of the first stage of dark culture are: 25°C, 180-250rpm, dark culture for 2 weeks; The conditions for the second stage of dark-proof culture are: 10° C., 180-250 rpm, dark-proof culture for 2 weeks.
5. The preparation method according to claim 1, characterized in that: The number of extractions in step (2) is 4 times; the volume percentage of methanol in the methanol aqueous solution is 50%; the amount of methanol aqueous solution used in each extraction is 150-300 mL; the volume ratio of ether to water in the ether aqueous solution is 1:
1.
6. The preparation method according to claim 1, characterized in that: The extraction times in step (3) are 3 times; and the amount of ethyl acetate used in each extraction is 20 mL.
7. The preparation method according to claim 1, characterized in that: The extraction times in step (5) are 3 times; and the amount of chloroform used in each extraction is 10 mL.
8. A method for detecting mycotoxin AOD and its derivatives, characterized in that: The following steps are involved: Liquid chromatography-tandem mass spectrometry was used to detect the fungal toxin AOD; Among them, mobile phase A is an aqueous solution of methanol-formic acid containing ammonium formate, and the volume ratio of methanol, water and formic acid in the aqueous solution of methanol-formic acid containing ammonium formate is 58:41:1; mobile phase B is a methanol-formic acid solution containing ammonium formate; the volume ratio of methanol and formic acid in the methanol-formic acid solution containing ammonium formate is 99:1; the concentration of ammonium formate in the mobile phase A and the mobile phase B is 5mM.
9. The detection method according to claim 8, characterized in that: The chromatographic column used in the liquid chromatography-tandem mass spectrometry was ZORBAX Eclipse Plus C18, and the sample loading volume was 10 μL.
10. The detection method according to claim 8, characterized in that: The liquid chromatography-tandem mass spectrometry detection performs qualitative analysis on the fungal toxin AOD through the MS2 scanning mode, and performs quantitative analysis on the fungal toxin AOD through the MRM mode.
Citation Information
Patent Citations
Method for extracting toxins from Isaria fumosorosea, and application of toxins
CN110915819A
Prodrugs of hydroxyl-comprising drugs
WO2013160340A1
